The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Studies Say People with Rheumatic Disease Face Work Challenges

Studies Say People with Rheumatic Disease Face Work Challenges

September 11, 2020 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Aleksandar Malivuk; Hryshchyshen Serhii; Iakov Filimonov; Krisha Vishinpir; Russamee; sutlafk; Svitlana Hulko; yangtak / shutterstock.com

Aleksandar Malivuk; Hryshchyshen Serhii; Iakov Filimonov; Krisha Vishinpir; Russamee; sutlafk; Svitlana Hulko; yangtak / shutterstock.com

EULAR 2020 e-CONGRESS—People with rheumatic diseases have more difficulty than others leading a work life, and researchers are attempting to quantify just how long they are able to remain healthy and working compared with the general population.

You Might Also Like
  • Global Life Expectancy Rises, but People Live Sicker for Longer
  • 2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care
  • Program May Prevent Work Loss for Patients with Rheumatic Diseases
Explore This Issue
September 2020
Also By This Author
  • Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

This topic is particularly pressing because people are now expected to work for a longer and longer periods of time. In Europe, the pension age has been getting older, and this trend is expected to continue, said Ross Wilkie, MD, a senior lecturer in public health and epidemiology at Keele University, Newcastle, U.K., in a talk at the European e-Congress of Rheumatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the United Kingdom, for example, the pension age was 65 in 2018. It is expected to be 67 by 2028 and 68 sometime between 2037 and 2039, Dr. Wilkie said. For people struggling with the pain associated with such diseases as osteoarthritis and other rheumatic diseases, keeping up that pace is likely to be a challenge.

“It’s unclear whether people will be healthy enough to continue to work for longer, and this is particularly prevalent in people with rheumatic diseases, who are more likely to experience early retirement—more likely to experience work absence, absenteeism—than people who don’t have rheumatic diseases,” he said. “Can people with rheumatic diseases work for longer in line with policies to extend working life?”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Researchers examined two datasets—the English Longitudinal Study of Ageing (ELSA) and the Survey of Health, Ageing and Retirement in Europe (SHARE)—to determine the healthy work-life expectancy of people with rheumatic diseases and explore associated factors. The healthy work-life expectancy, as they defined it, is the number of years that people are healthy and working after age 50, with healthy meaning no physical or mental impairments that inhibit the performance of normal day-to-day activities.

The overall healthy work-life expectancy for people in England, they found, was 9.42 years, meaning those at age 50 can expect to work for about nine-and-half more years. This figure for people with osteoarthritis was just 5.58 years. The study is in press with Lancet Public Health.

Researchers also assessed physical activity and found those with osteo­arthritis (OA) who say they participate in moderate physical activity at least more than once a week have a longer healthy work-life expectancy (just under eight years) than those who do not engage in this activity (just under four years). The healthy work-life expectancy was also longer for those who say they’re physically active among those without OA, Dr. Wilkie said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Physical activity can be one factor that can lead to improvements in healthy work-life expectancy,” Dr. Wilkie said.

Dr. Wilkie pointed out the data paint different pictures of healthy working life around countries in Europe. For example, the healthy work-life expectancy in England is similar to that of Denmark and Sweden—two countries combined for the sake of the analysis—at about five years, but higher than Belgium and Spain, which both have a healthy work-life expectancy below four years. The results in Denmark and Sweden show more people are expected to have more years of not being healthy but still working, which could be a sign those countries make arrangements for members of the workforce who are not well so they can continue employment.

“The estimates of healthy work-life expectancy in this study question whether people will be able to extend their working lives to the level that govern­ments would like by increasing state pension age,” Dr. Wilkie said. “This varies by country, but this variation indicates that there are methods that we could be using to maintain, and actually increase, healthy work-life expectancy. But we need further research to be able to indicate what they are.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Patient Perspective Tagged With: Chronic pain, EULAR 2020, workIssue: September 2020

You Might Also Like:
  • Global Life Expectancy Rises, but People Live Sicker for Longer
  • 2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care
  • Program May Prevent Work Loss for Patients with Rheumatic Diseases
  • People with Rheumatic Diseases Should Pay Extra Attention to Self-Care During COVID-19

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.